CivicGraph — Due Diligence Pack

Australian Genomic Cancer Medicine Centre Limited

ABN 67627640733charity • Generated 2026-03-24
Executive Summary
  • Reported a $6.8M surplus in 2023 — financially healthy.
  • Clean political record — no political donations on file.
Entity Type
charity
State
NSW
SEIFA DecileSocio-Economic Indexes for Areas — decile 1 is most disadvantaged, 10 is least
Community Ctrl
No
Remoteness
Major Cities of Australia
LGA
Sydney
Size: Large • HPC (Health Promotion Charity — tax-deductible donations) • Purposes: Health, Social Welfare
Financial Summary
Latest Revenue
$25.3M
Latest Expenses
$18.5M
Total Assets
$64.2M
YearRevenueExpensesAssetsSurplusGov RevFTE
2023$25.3M$18.5M$64.2M$6.8M$16.3M2
2022$16.5M$14.7M$20.8M$1.8M$11.8M1
2021$15.9M$12.8M$20.5M$3.2M$10.4M1
2020$10.9M$9.2M$13.2M$1.7M$10.0M2
2019$10.1M$1.1M$9.0M$8.9M$10.0M1
Government Funding

No government funding records found — clean record in tracked datasets.

Government Contracts

No AusTender contracts on record — clean procurement record.

Political Connections

No political donation records — clean political record.

Evidence Alignment (ALMAAustralian Living Map of Alternatives — JusticeHub's evidence database of what works)

No evidence-backed programs (ALMA) linked yet — this entity may operate programs not yet catalogued in the Australian Living Map of Alternatives.

Geographic Context
Locality
Camperdown - Darlington
Remoteness
Local Ecosystem
52 orgs
Integrity Assessment
ABN registered
ACNC financials available
Evidence-backed programs (ALMA)
Government funding received
Government contracts held
No political donations
No donations + contracts overlap
Serves disadvantaged area
Data Sources & Citation
CivicGraph Due Diligence Pack: Australian Genomic Cancer Medicine Centre Limited (ABN 67627640733). Generated 2026-03-24. Data sources: CivicGraph Entity Graph, ACNC, AusTender, AEC, ALMA.
CivicGraph — Decision Infrastructure for Government & Social Sector

This due diligence pack is auto-generated from public data sources. Verify critical claims against primary sources before inclusion in formal submissions.